share_log

bluebird bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-BlackRock, Inc.(4.7%)

SEC announcement ·  Jan 8 00:00
Summary by Moomoo AI
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on January 8, 2024, indicating a change in its holdings in bluebird bio, a biotechnology company. The filing, dated December 31, 2023, shows that BlackRock now beneficially owns 8,983,001 shares of bluebird bio's common stock, which represents 4.7% of the company's class of securities. This marks a decrease in ownership, as BlackRock has checked the box indicating that it has ceased to be the beneficial owner of more than 5 percent of the class of securities. The filing also details that BlackRock has sole voting power over 8,832,224 shares and sole dispositive power over all 8,983,001 shares it owns. The address of bluebird bio's principal executive offices is listed as 455 Grand Union Boulevard, Somerville, MA 02145.
BlackRock, Inc., a major investment management corporation based in Delaware, has filed an amended Schedule 13G with the Securities and Exchange Commission on January 8, 2024, indicating a change in its holdings in bluebird bio, a biotechnology company. The filing, dated December 31, 2023, shows that BlackRock now beneficially owns 8,983,001 shares of bluebird bio's common stock, which represents 4.7% of the company's class of securities. This marks a decrease in ownership, as BlackRock has checked the box indicating that it has ceased to be the beneficial owner of more than 5 percent of the class of securities. The filing also details that BlackRock has sole voting power over 8,832,224 shares and sole dispositive power over all 8,983,001 shares it owns. The address of bluebird bio's principal executive offices is listed as 455 Grand Union Boulevard, Somerville, MA 02145.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more